| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745732 | Parkinsonism & Related Disorders | 2013 | 5 Pages |
Abstract
This study demonstrated for the first time in Chinese subjects that ropinirole PR improved Parkinson's disease symptoms, permitting a reduction in L-dopa dose. The adverse events observed were consistent with the established safety profile of ropinirole, with no new safety signal identified.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, Shengdi Chen, Zhenfu Wang, Baorong Zhang, Chunfeng Liu, Qiumin Qu, Yan Cheng, Jie Li, Haijun Cao, Meng Cai, Rongxuan Zhu,